Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin in Patients at Clinical Risk for Psychosis
NCT02557945Phase 2Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in schizophrenia, sponsored by New York State Psychiatric Institute. Started Aug 2015; status: terminated.
02
Drugs
gabapentin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02557945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02557945.